Circulation, published online July 12, 2017; Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency Dirk J. van Veldhuisen, MD 1; Piotr Ponikowski, MD2; Peter van der Meer, MD1; Marco Metra, MD3; Michael Böhm, MD4; Artem Doletsky, MD5; Adriaan A. Voors, MD1; Iain C. Macdougall, MD6; Stefan D. Anker, MD7; Bernard Roubert, PhD8; Lorraine Zakin, MD8; Alain Cohen-Solal, MD9; for the EFFECT-HF Investigators ...
Read More

European Heart Journal, Published 21 August 2014 Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Piotr Ponikowski1,2*, Dirk J. van Veldhuisen3, Josep Comin-Colet4, Georg Ertl5,6 ,Michel Komajda7 ,Viacheslav Mareev8, Theresa Mc Donagh9, Alexander Parkhomenko10, Luigi Tavazzi11, Victoria Levesque12, Claudio Mori12, Bernard Roubert12, Gerasimos Filippatos13, Frank Ruschitzka14, and Stefan D. Anker15, for the CONFIRM-HF Investigators 1Department of Heart Diseases, Medical ...
Read More

N engl j med 361;25 nejm.org december 17, 2009 Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency Stefan D. Anker, M.D., Ph.D., Josep Comin Colet, M.D., Gerasimos Filippatos, M.D., Ronnie Willenheimer, M.D., Kenneth Dickstein, M.D., Ph.D., Helmut Drexler, M.D.,1Thomas F. Lüscher, M.D., Boris Bart, M.D., Waldemar Banasiak, M.D., Ph.D., Joanna Niegowska, M.D., Bridget-Anne Kirwan, Ph.D., Claudio Mori, M.D., Barbara von Eisenhart Rothe, M.D., Stuart J. Pocock, Ph.D., Philip ...
Read More